Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amyloidosis | 123 | 2024 | 876 | 16.320 |
Why?
|
Amyloid Neuropathies, Familial | 26 | 2024 | 180 | 8.190 |
Why?
|
Cardiomyopathies | 78 | 2024 | 2057 | 7.850 |
Why?
|
Prealbumin | 40 | 2024 | 259 | 6.260 |
Why?
|
Immunoglobulin Light Chains | 18 | 2024 | 289 | 2.500 |
Why?
|
Benzoxazoles | 5 | 2022 | 92 | 1.930 |
Why?
|
Electric Countershock | 13 | 2024 | 534 | 1.810 |
Why?
|
Anti-Arrhythmia Agents | 17 | 2012 | 773 | 1.790 |
Why?
|
Heart Diseases | 20 | 2020 | 2817 | 1.670 |
Why?
|
Atrial Fibrillation | 41 | 2024 | 5180 | 1.600 |
Why?
|
Myocardium | 33 | 2024 | 4765 | 1.490 |
Why?
|
Heart Failure | 33 | 2024 | 11877 | 1.410 |
Why?
|
Radionuclide Imaging | 14 | 2022 | 1987 | 1.370 |
Why?
|
Echocardiography | 36 | 2024 | 5042 | 1.330 |
Why?
|
Ethylene Glycols | 8 | 2024 | 197 | 1.320 |
Why?
|
Amyloid | 18 | 2023 | 849 | 1.230 |
Why?
|
Ventricular Function, Left | 14 | 2024 | 3934 | 1.180 |
Why?
|
Aniline Compounds | 8 | 2024 | 1080 | 0.980 |
Why?
|
Technetium | 9 | 2022 | 325 | 0.890 |
Why?
|
Heart | 14 | 2022 | 4429 | 0.840 |
Why?
|
Electrocardiography | 34 | 2019 | 6409 | 0.820 |
Why?
|
Echocardiography, Doppler | 12 | 2020 | 898 | 0.810 |
Why?
|
Serum Amyloid P-Component | 1 | 2022 | 46 | 0.780 |
Why?
|
Atrial Function, Left | 4 | 2017 | 188 | 0.770 |
Why?
|
Carboxylic Acids | 1 | 2022 | 91 | 0.760 |
Why?
|
Digoxin | 10 | 2002 | 246 | 0.710 |
Why?
|
Amiodarone | 3 | 2012 | 217 | 0.690 |
Why?
|
Pyrrolidines | 1 | 2022 | 339 | 0.680 |
Why?
|
Echocardiography, Doppler, Pulsed | 3 | 2005 | 68 | 0.660 |
Why?
|
Atrial Flutter | 7 | 2003 | 253 | 0.660 |
Why?
|
Melphalan | 13 | 2011 | 421 | 0.640 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2022 | 1337 | 0.610 |
Why?
|
Myeloma Proteins | 2 | 2019 | 71 | 0.610 |
Why?
|
Echocardiography, Transesophageal | 1 | 2024 | 1096 | 0.600 |
Why?
|
Predictive Value of Tests | 25 | 2024 | 15424 | 0.590 |
Why?
|
Cardiomyopathy, Restrictive | 4 | 2015 | 61 | 0.590 |
Why?
|
Humans | 243 | 2024 | 767040 | 0.580 |
Why?
|
Myocardial Contraction | 7 | 2010 | 1516 | 0.570 |
Why?
|
Technetium Tc 99m Pyrophosphate | 8 | 2024 | 52 | 0.570 |
Why?
|
Diphosphates | 7 | 2022 | 89 | 0.560 |
Why?
|
Tachycardia | 7 | 2000 | 598 | 0.510 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2017 | 176 | 0.500 |
Why?
|
Ventricular Fibrillation | 3 | 2008 | 538 | 0.490 |
Why?
|
Phenethylamines | 3 | 2000 | 95 | 0.490 |
Why?
|
Positron-Emission Tomography | 5 | 2022 | 6550 | 0.490 |
Why?
|
Cardiac Pacing, Artificial | 10 | 1995 | 881 | 0.470 |
Why?
|
Echocardiography, Doppler, Color | 3 | 2015 | 353 | 0.460 |
Why?
|
Tendon Injuries | 1 | 2017 | 329 | 0.440 |
Why?
|
Disopyramide | 2 | 2012 | 16 | 0.440 |
Why?
|
Aged | 87 | 2024 | 171319 | 0.440 |
Why?
|
Bone Marrow Examination | 1 | 2013 | 154 | 0.430 |
Why?
|
Magnetic Resonance Imaging | 10 | 2024 | 36582 | 0.430 |
Why?
|
Systole | 8 | 2018 | 935 | 0.420 |
Why?
|
Blood Flow Velocity | 6 | 2014 | 1374 | 0.420 |
Why?
|
Gadolinium DTPA | 2 | 2015 | 823 | 0.410 |
Why?
|
Atrial Function | 4 | 2015 | 98 | 0.400 |
Why?
|
Anticoagulants | 7 | 2007 | 4854 | 0.400 |
Why?
|
Male | 123 | 2024 | 364203 | 0.400 |
Why?
|
Magnetic Resonance Imaging, Cine | 8 | 2024 | 1092 | 0.400 |
Why?
|
Heart Rate | 15 | 2006 | 4209 | 0.390 |
Why?
|
Radiopharmaceuticals | 8 | 2024 | 2702 | 0.390 |
Why?
|
Posture | 2 | 2014 | 956 | 0.380 |
Why?
|
Middle Aged | 105 | 2024 | 223233 | 0.370 |
Why?
|
Immunoglobulin kappa-Chains | 3 | 2020 | 171 | 0.370 |
Why?
|
Female | 113 | 2024 | 396660 | 0.360 |
Why?
|
Calcium Channel Blockers | 4 | 2011 | 688 | 0.360 |
Why?
|
Myxoma | 1 | 2011 | 114 | 0.350 |
Why?
|
Cardiology | 5 | 2020 | 1701 | 0.350 |
Why?
|
Potassium Channel Blockers | 2 | 2000 | 162 | 0.340 |
Why?
|
Microvessels | 1 | 2014 | 585 | 0.340 |
Why?
|
Stroke Volume | 12 | 2022 | 5618 | 0.330 |
Why?
|
Heart Failure, Systolic | 1 | 2011 | 134 | 0.330 |
Why?
|
Dyspnea | 3 | 2014 | 1352 | 0.320 |
Why?
|
Warfarin | 9 | 2004 | 1493 | 0.320 |
Why?
|
Cardiomyopathy, Dilated | 5 | 2004 | 843 | 0.320 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2018 | 1076 | 0.310 |
Why?
|
Paraproteinemias | 4 | 2020 | 251 | 0.310 |
Why?
|
Natriuretic Peptide, Brain | 4 | 2024 | 1749 | 0.310 |
Why?
|
Heart Conduction System | 5 | 2000 | 1008 | 0.310 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2337 | 0.310 |
Why?
|
Colchicine | 4 | 2024 | 256 | 0.300 |
Why?
|
Verapamil | 4 | 2002 | 242 | 0.300 |
Why?
|
Military Personnel | 1 | 2017 | 1261 | 0.300 |
Why?
|
Antibodies, Monoclonal | 3 | 2022 | 9245 | 0.290 |
Why?
|
Prognosis | 26 | 2024 | 29963 | 0.290 |
Why?
|
Aortic Valve Stenosis | 1 | 2020 | 2021 | 0.290 |
Why?
|
Heart Atria | 7 | 2021 | 1362 | 0.290 |
Why?
|
Heart Neoplasms | 1 | 2011 | 374 | 0.280 |
Why?
|
Mitral Valve Stenosis | 2 | 2004 | 342 | 0.280 |
Why?
|
Wolff-Parkinson-White Syndrome | 2 | 2000 | 117 | 0.280 |
Why?
|
Ventricular Dysfunction, Left | 6 | 2014 | 2144 | 0.270 |
Why?
|
Fluorine Radioisotopes | 2 | 2020 | 405 | 0.270 |
Why?
|
Hypercalcemia | 1 | 2009 | 424 | 0.270 |
Why?
|
Pacemaker, Artificial | 5 | 2001 | 828 | 0.260 |
Why?
|
Diagnosis, Differential | 12 | 2016 | 12986 | 0.250 |
Why?
|
Tachycardia, Ventricular | 3 | 2008 | 1313 | 0.250 |
Why?
|
Sulfonamides | 3 | 2000 | 1982 | 0.250 |
Why?
|
Biopsy | 11 | 2021 | 6777 | 0.250 |
Why?
|
Amyloidosis, Familial | 2 | 2002 | 16 | 0.250 |
Why?
|
Contrast Media | 4 | 2021 | 5329 | 0.250 |
Why?
|
Drug Therapy, Combination | 8 | 2022 | 6310 | 0.250 |
Why?
|
Acenocoumarol | 1 | 2004 | 18 | 0.240 |
Why?
|
Arrhythmias, Cardiac | 8 | 2005 | 2257 | 0.240 |
Why?
|
Aged, 80 and over | 24 | 2024 | 59548 | 0.240 |
Why?
|
Multiple Myeloma | 2 | 2013 | 5186 | 0.240 |
Why?
|
American Heart Association | 2 | 2019 | 1049 | 0.230 |
Why?
|
Catheter Ablation | 4 | 2015 | 2787 | 0.230 |
Why?
|
Salicylates | 1 | 2004 | 127 | 0.230 |
Why?
|
Sarcoidosis | 1 | 2010 | 535 | 0.230 |
Why?
|
Familial Mediterranean Fever | 1 | 2024 | 66 | 0.220 |
Why?
|
Diastole | 5 | 2014 | 784 | 0.220 |
Why?
|
Hypertrophy, Left Ventricular | 3 | 2014 | 856 | 0.220 |
Why?
|
Mutation | 10 | 2020 | 30211 | 0.210 |
Why?
|
Automobile Driving | 1 | 2008 | 442 | 0.210 |
Why?
|
Protein Folding | 2 | 2018 | 869 | 0.210 |
Why?
|
Prevalence | 10 | 2020 | 15851 | 0.210 |
Why?
|
Immunoglobulin lambda-Chains | 2 | 2017 | 84 | 0.210 |
Why?
|
Coronary Vessels | 1 | 2014 | 3114 | 0.210 |
Why?
|
Heart Transplantation | 6 | 2024 | 3305 | 0.210 |
Why?
|
Sotalol | 3 | 2003 | 47 | 0.210 |
Why?
|
Diagnostic Imaging | 3 | 2011 | 3530 | 0.200 |
Why?
|
Flecainide | 2 | 1994 | 41 | 0.200 |
Why?
|
Cardiac Imaging Techniques | 2 | 2021 | 280 | 0.190 |
Why?
|
Intracranial Hemorrhages | 1 | 2007 | 810 | 0.190 |
Why?
|
Plasma Cells | 2 | 2017 | 599 | 0.190 |
Why?
|
Tellurium | 1 | 2020 | 24 | 0.180 |
Why?
|
Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography | 1 | 2020 | 6 | 0.180 |
Why?
|
Defibrillators, Implantable | 2 | 2008 | 1499 | 0.180 |
Why?
|
Adrenergic beta-Antagonists | 4 | 2011 | 1243 | 0.180 |
Why?
|
Heart Auscultation | 1 | 2000 | 33 | 0.180 |
Why?
|
RNA, Small Interfering | 2 | 2020 | 3427 | 0.180 |
Why?
|
Coitus | 1 | 2001 | 132 | 0.180 |
Why?
|
Early Diagnosis | 3 | 2020 | 1188 | 0.170 |
Why?
|
Pleural Effusion | 1 | 2003 | 344 | 0.170 |
Why?
|
Amyloidogenic Proteins | 2 | 2023 | 151 | 0.170 |
Why?
|
Amino Acid Substitution | 3 | 2020 | 1743 | 0.170 |
Why?
|
Heart Ventricles | 11 | 2024 | 3837 | 0.160 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2001 | 239 | 0.160 |
Why?
|
Time Factors | 11 | 2024 | 40154 | 0.160 |
Why?
|
Cadmium | 1 | 2020 | 218 | 0.160 |
Why?
|
Stem Cell Transplantation | 4 | 2011 | 1596 | 0.160 |
Why?
|
Placebos | 3 | 2019 | 1660 | 0.160 |
Why?
|
Ultrasonography | 9 | 2015 | 6000 | 0.160 |
Why?
|
Societies, Medical | 3 | 2020 | 3964 | 0.160 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 1997 | 1458 | 0.160 |
Why?
|
Treatment Outcome | 20 | 2024 | 65295 | 0.150 |
Why?
|
Sinoatrial Node | 2 | 1995 | 99 | 0.150 |
Why?
|
Electrodes | 2 | 1993 | 612 | 0.150 |
Why?
|
Gadolinium | 2 | 2018 | 964 | 0.150 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2024 | 645 | 0.150 |
Why?
|
Adenosine | 1 | 2003 | 812 | 0.150 |
Why?
|
Tachycardia, Supraventricular | 3 | 2015 | 272 | 0.150 |
Why?
|
Pulmonary Veins | 3 | 2011 | 761 | 0.150 |
Why?
|
Disease Progression | 9 | 2020 | 13646 | 0.150 |
Why?
|
Hospitalization | 6 | 2019 | 10815 | 0.140 |
Why?
|
Coronary Circulation | 3 | 2014 | 1603 | 0.140 |
Why?
|
Benzoates | 1 | 2019 | 213 | 0.140 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2004 | 2764 | 0.140 |
Why?
|
Risk Factors | 15 | 2024 | 74886 | 0.140 |
Why?
|
Rupture, Spontaneous | 1 | 2017 | 365 | 0.140 |
Why?
|
Quality of Life | 5 | 2024 | 13485 | 0.130 |
Why?
|
Radioactive Tracers | 2 | 2020 | 61 | 0.130 |
Why?
|
Antineoplastic Agents, Alkylating | 5 | 2004 | 614 | 0.130 |
Why?
|
Peptide Fragments | 3 | 2024 | 5141 | 0.130 |
Why?
|
Zinc | 1 | 2020 | 675 | 0.130 |
Why?
|
Drug Administration Schedule | 4 | 2015 | 4855 | 0.130 |
Why?
|
Heart Function Tests | 2 | 2010 | 316 | 0.130 |
Why?
|
Pulse | 1 | 1996 | 217 | 0.130 |
Why?
|
Survival Analysis | 11 | 2019 | 10092 | 0.130 |
Why?
|
Immunosuppressive Agents | 4 | 2010 | 4210 | 0.130 |
Why?
|
Stroke | 4 | 2007 | 9746 | 0.120 |
Why?
|
Cerebrovascular Disorders | 5 | 1998 | 1478 | 0.120 |
Why?
|
Adult | 52 | 2020 | 223317 | 0.120 |
Why?
|
Genotype | 3 | 2020 | 13035 | 0.120 |
Why?
|
Longitudinal Studies | 7 | 2024 | 14766 | 0.120 |
Why?
|
Thyrotoxicosis | 1 | 1995 | 85 | 0.120 |
Why?
|
Syncope | 1 | 1997 | 431 | 0.120 |
Why?
|
Esophageal Achalasia | 1 | 1995 | 98 | 0.120 |
Why?
|
Decision Trees | 1 | 2016 | 508 | 0.120 |
Why?
|
Arm | 1 | 2017 | 591 | 0.110 |
Why?
|
Cardiac Output | 1 | 1997 | 837 | 0.110 |
Why?
|
Ventricular Remodeling | 1 | 2022 | 1281 | 0.110 |
Why?
|
Diuretics | 2 | 2011 | 614 | 0.110 |
Why?
|
International Normalized Ratio | 2 | 2007 | 382 | 0.110 |
Why?
|
Prospective Studies | 14 | 2024 | 54886 | 0.110 |
Why?
|
Protein Structure, Quaternary | 1 | 2015 | 424 | 0.110 |
Why?
|
Disease Management | 2 | 2020 | 2531 | 0.110 |
Why?
|
Vasomotor System | 1 | 2014 | 208 | 0.110 |
Why?
|
Case-Control Studies | 5 | 2019 | 22254 | 0.110 |
Why?
|
Consensus | 5 | 2021 | 3207 | 0.110 |
Why?
|
Thromboembolism | 3 | 1998 | 1003 | 0.110 |
Why?
|
Women's Health | 1 | 2023 | 2082 | 0.110 |
Why?
|
Death, Sudden, Cardiac | 4 | 2010 | 1567 | 0.110 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1791 | 0.110 |
Why?
|
Mass Spectrometry | 3 | 2018 | 2201 | 0.110 |
Why?
|
Cardiotoxins | 1 | 2013 | 36 | 0.110 |
Why?
|
Lupus Nephritis | 1 | 1997 | 324 | 0.110 |
Why?
|
Physical Exertion | 2 | 1996 | 667 | 0.110 |
Why?
|
Marfan Syndrome | 1 | 1995 | 237 | 0.110 |
Why?
|
Electrocardiography, Ambulatory | 4 | 1998 | 582 | 0.110 |
Why?
|
United States | 13 | 2022 | 72971 | 0.110 |
Why?
|
Protein Stability | 1 | 2015 | 578 | 0.110 |
Why?
|
Survival Rate | 8 | 2005 | 12823 | 0.110 |
Why?
|
Immunoglobulin M | 1 | 2018 | 1527 | 0.110 |
Why?
|
Magnesium | 1 | 1996 | 815 | 0.100 |
Why?
|
Hyperemia | 1 | 2014 | 223 | 0.100 |
Why?
|
Reproducibility of Results | 5 | 2020 | 20169 | 0.100 |
Why?
|
Severity of Illness Index | 7 | 2024 | 15925 | 0.100 |
Why?
|
Electrophysiology | 3 | 2001 | 1263 | 0.100 |
Why?
|
Clinical Trials as Topic | 8 | 2012 | 8048 | 0.100 |
Why?
|
Biopsy, Needle | 2 | 2011 | 1615 | 0.100 |
Why?
|
Thalidomide | 2 | 2011 | 886 | 0.100 |
Why?
|
Myocardial Infarction | 5 | 2009 | 11513 | 0.100 |
Why?
|
Heart Septal Defects, Atrial | 2 | 1995 | 452 | 0.100 |
Why?
|
ROC Curve | 2 | 2015 | 3618 | 0.100 |
Why?
|
Dogs | 2 | 2016 | 3834 | 0.100 |
Why?
|
Aspirin | 6 | 2004 | 3135 | 0.100 |
Why?
|
Double-Blind Method | 10 | 2019 | 12451 | 0.090 |
Why?
|
Cyclophosphamide | 1 | 1997 | 2227 | 0.090 |
Why?
|
Organ Specificity | 2 | 2014 | 1966 | 0.090 |
Why?
|
Alleles | 2 | 2020 | 6893 | 0.090 |
Why?
|
Liver Transplantation | 3 | 1998 | 2416 | 0.090 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2013 | 694 | 0.090 |
Why?
|
Myocardial Ischemia | 1 | 2001 | 2131 | 0.090 |
Why?
|
Evidence-Based Medicine | 4 | 2021 | 3700 | 0.090 |
Why?
|
Ventricular Dysfunction | 2 | 2001 | 143 | 0.090 |
Why?
|
Pulmonary Wedge Pressure | 1 | 1991 | 277 | 0.090 |
Why?
|
Heart Valve Prosthesis | 3 | 2010 | 1464 | 0.090 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4560 | 0.090 |
Why?
|
Protein Multimerization | 1 | 2015 | 961 | 0.080 |
Why?
|
Thrombosis | 2 | 1995 | 2954 | 0.080 |
Why?
|
Biological Transport | 1 | 2014 | 2084 | 0.080 |
Why?
|
Follow-Up Studies | 11 | 2015 | 39317 | 0.080 |
Why?
|
Norepinephrine | 1 | 1992 | 898 | 0.080 |
Why?
|
Recurrence | 6 | 2015 | 8504 | 0.080 |
Why?
|
Antibodies | 1 | 2017 | 2419 | 0.080 |
Why?
|
Lysosomes | 1 | 2014 | 937 | 0.080 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2011 | 1515 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2014 | 12069 | 0.080 |
Why?
|
Epinephrine | 1 | 1992 | 782 | 0.080 |
Why?
|
Tinnitus | 1 | 2011 | 197 | 0.080 |
Why?
|
Pyrazoles | 1 | 2019 | 2028 | 0.080 |
Why?
|
Atropine | 2 | 1986 | 243 | 0.080 |
Why?
|
Hidradenitis Suppurativa | 1 | 2012 | 176 | 0.080 |
Why?
|
Atherosclerosis | 1 | 2024 | 3418 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2020 | 3561 | 0.070 |
Why?
|
Europe | 3 | 2020 | 3432 | 0.070 |
Why?
|
Peer Review | 1 | 1990 | 218 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 6 | 2004 | 5716 | 0.070 |
Why?
|
Plaque, Amyloid | 1 | 2012 | 769 | 0.070 |
Why?
|
Pilot Projects | 3 | 2023 | 8732 | 0.070 |
Why?
|
Boronic Acids | 1 | 2011 | 915 | 0.070 |
Why?
|
Pulmonary Circulation | 1 | 2010 | 744 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2006 | 10393 | 0.070 |
Why?
|
Carotid Sinus | 1 | 1986 | 44 | 0.070 |
Why?
|
Capsules | 1 | 1987 | 193 | 0.070 |
Why?
|
Propranolol | 1 | 1988 | 493 | 0.070 |
Why?
|
Heart Massage | 1 | 1986 | 32 | 0.070 |
Why?
|
Amyloid Neuropathies | 2 | 1998 | 14 | 0.070 |
Why?
|
Alopecia | 1 | 2011 | 416 | 0.070 |
Why?
|
Autophagy | 1 | 2014 | 1347 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2020 | 8940 | 0.070 |
Why?
|
Delphi Technique | 2 | 2021 | 891 | 0.070 |
Why?
|
Myocytes, Cardiac | 2 | 2013 | 1672 | 0.070 |
Why?
|
Mitral Valve | 3 | 2010 | 1475 | 0.070 |
Why?
|
Nuclear Medicine | 2 | 2019 | 262 | 0.060 |
Why?
|
Atrioventricular Node | 1 | 1986 | 180 | 0.060 |
Why?
|
Glycoproteins | 1 | 2013 | 2200 | 0.060 |
Why?
|
Pyrazines | 1 | 2011 | 1204 | 0.060 |
Why?
|
Apoptosis | 2 | 2013 | 9513 | 0.060 |
Why?
|
Retrospective Studies | 6 | 2022 | 81659 | 0.060 |
Why?
|
Remission Induction | 4 | 2019 | 2408 | 0.060 |
Why?
|
Blood Proteins | 1 | 2011 | 1190 | 0.060 |
Why?
|
Observer Variation | 2 | 2010 | 2616 | 0.060 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 1326 | 0.060 |
Why?
|
Quinidine | 1 | 1984 | 52 | 0.060 |
Why?
|
Exercise Test | 4 | 1997 | 2188 | 0.060 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2011 | 562 | 0.060 |
Why?
|
Benzeneacetamides | 1 | 1984 | 36 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2017 | 3370 | 0.060 |
Why?
|
Extracellular Matrix | 1 | 2012 | 1733 | 0.060 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2011 | 1065 | 0.060 |
Why?
|
Infusions, Intravenous | 5 | 2019 | 2227 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10869 | 0.060 |
Why?
|
Magnetic Resonance Angiography | 1 | 2011 | 1429 | 0.060 |
Why?
|
Scoliosis | 1 | 2011 | 793 | 0.060 |
Why?
|
Incidence | 3 | 2019 | 21526 | 0.060 |
Why?
|
Dexamethasone | 1 | 2011 | 1963 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 2 | 2015 | 6513 | 0.050 |
Why?
|
Linear Models | 2 | 2012 | 5875 | 0.050 |
Why?
|
Sensitivity and Specificity | 4 | 2005 | 14672 | 0.050 |
Why?
|
Hemodynamics | 4 | 2001 | 4186 | 0.050 |
Why?
|
Cardiovascular Agents | 1 | 2010 | 849 | 0.050 |
Why?
|
Inhalation Exposure | 1 | 2006 | 432 | 0.050 |
Why?
|
California | 1 | 2007 | 1439 | 0.050 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2003 | 98 | 0.050 |
Why?
|
Phenotype | 2 | 2020 | 16718 | 0.050 |
Why?
|
Nutrition Disorders | 1 | 1983 | 204 | 0.050 |
Why?
|
Risk Assessment | 4 | 2024 | 24299 | 0.050 |
Why?
|
Age Factors | 4 | 2019 | 18401 | 0.050 |
Why?
|
Molecular Imaging | 2 | 2019 | 822 | 0.050 |
Why?
|
Carbon | 1 | 2006 | 672 | 0.050 |
Why?
|
Nephrotic Syndrome | 3 | 2001 | 381 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2004 | 10748 | 0.050 |
Why?
|
Diltiazem | 1 | 2002 | 132 | 0.050 |
Why?
|
Random Allocation | 4 | 1988 | 2394 | 0.050 |
Why?
|
Cardiac Tamponade | 1 | 1983 | 175 | 0.050 |
Why?
|
Proportional Hazards Models | 2 | 2010 | 12536 | 0.050 |
Why?
|
Pleura | 1 | 2003 | 245 | 0.050 |
Why?
|
Particle Size | 1 | 2006 | 1633 | 0.050 |
Why?
|
Animals | 9 | 2017 | 168965 | 0.050 |
Why?
|
Lymphangiomyoma | 1 | 2001 | 9 | 0.050 |
Why?
|
Alkylating Agents | 1 | 2001 | 132 | 0.050 |
Why?
|
Evaluation Studies as Topic | 3 | 1991 | 1623 | 0.050 |
Why?
|
Blood Pressure | 3 | 2004 | 8531 | 0.050 |
Why?
|
Food-Drug Interactions | 1 | 2000 | 26 | 0.050 |
Why?
|
Medicare | 1 | 2019 | 6813 | 0.050 |
Why?
|
Referral and Consultation | 2 | 2011 | 3618 | 0.040 |
Why?
|
Pre-Excitation Syndromes | 1 | 2000 | 27 | 0.040 |
Why?
|
Organotechnetium Compounds | 1 | 2020 | 134 | 0.040 |
Why?
|
Early Termination of Clinical Trials | 1 | 2020 | 70 | 0.040 |
Why?
|
Heterozygote | 2 | 2015 | 2794 | 0.040 |
Why?
|
Cause of Death | 3 | 2020 | 3717 | 0.040 |
Why?
|
Sensory Thresholds | 2 | 1993 | 377 | 0.040 |
Why?
|
Technetium Tc 99m Medronate | 2 | 2018 | 134 | 0.040 |
Why?
|
Cohort Studies | 6 | 2023 | 41718 | 0.040 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2007 | 887 | 0.040 |
Why?
|
Heart Arrest | 2 | 1986 | 1516 | 0.040 |
Why?
|
Exercise | 2 | 1997 | 5954 | 0.040 |
Why?
|
Granulocyte Colony-Stimulating Factor | 2 | 1999 | 631 | 0.040 |
Why?
|
Prednisone | 3 | 2004 | 1566 | 0.040 |
Why?
|
Fatal Outcome | 2 | 2010 | 1836 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 3 | 2020 | 18063 | 0.040 |
Why?
|
Knowledge | 1 | 2020 | 178 | 0.040 |
Why?
|
Electroencephalography | 1 | 2014 | 6282 | 0.040 |
Why?
|
Macroglossia | 1 | 1998 | 12 | 0.040 |
Why?
|
Finland | 1 | 2019 | 608 | 0.040 |
Why?
|
Coronary Care Units | 1 | 1979 | 235 | 0.040 |
Why?
|
Parotid Gland | 1 | 2019 | 178 | 0.040 |
Why?
|
Ecchymosis | 1 | 1998 | 32 | 0.040 |
Why?
|
Stress, Mechanical | 1 | 2003 | 1673 | 0.040 |
Why?
|
Zebrafish | 3 | 2014 | 3036 | 0.040 |
Why?
|
Immunohistochemistry | 3 | 2013 | 11063 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20741 | 0.040 |
Why?
|
Therapeutic Equivalency | 1 | 1998 | 135 | 0.040 |
Why?
|
Polyneuropathies | 1 | 2019 | 139 | 0.040 |
Why?
|
Combined Modality Therapy | 4 | 2002 | 8535 | 0.040 |
Why?
|
Reference Values | 2 | 2017 | 4918 | 0.040 |
Why?
|
Death Certificates | 1 | 2018 | 172 | 0.040 |
Why?
|
Syncope, Vasovagal | 1 | 1997 | 39 | 0.040 |
Why?
|
Patient Selection | 3 | 2001 | 4256 | 0.040 |
Why?
|
Hemolysis | 1 | 1979 | 417 | 0.040 |
Why?
|
Valine | 1 | 1999 | 410 | 0.040 |
Why?
|
Biological Availability | 1 | 1998 | 387 | 0.030 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 1997 | 109 | 0.030 |
Why?
|
Chemistry, Pharmaceutical | 1 | 1998 | 273 | 0.030 |
Why?
|
Prednisolone | 1 | 1998 | 326 | 0.030 |
Why?
|
Phonocardiography | 1 | 1996 | 30 | 0.030 |
Why?
|
Psychoses, Substance-Induced | 1 | 1977 | 98 | 0.030 |
Why?
|
Isoelectric Focusing | 3 | 2002 | 148 | 0.030 |
Why?
|
Alanine | 1 | 1999 | 613 | 0.030 |
Why?
|
Public Opinion | 1 | 2020 | 484 | 0.030 |
Why?
|
Piperidines | 1 | 1984 | 1667 | 0.030 |
Why?
|
Lung Diseases | 1 | 2006 | 1942 | 0.030 |
Why?
|
DNA | 1 | 2009 | 7210 | 0.030 |
Why?
|
Delayed Diagnosis | 1 | 2019 | 454 | 0.030 |
Why?
|
North America | 1 | 2019 | 1287 | 0.030 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1999 | 892 | 0.030 |
Why?
|
Hypertension | 2 | 2007 | 8615 | 0.030 |
Why?
|
Exercise Tolerance | 1 | 2020 | 846 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2019 | 2275 | 0.030 |
Why?
|
Rheumatic Heart Disease | 2 | 2010 | 163 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7435 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2127 | 0.030 |
Why?
|
Autoradiography | 1 | 2015 | 725 | 0.030 |
Why?
|
Membrane Potentials | 1 | 1997 | 1085 | 0.030 |
Why?
|
Physician-Patient Relations | 1 | 1987 | 3266 | 0.030 |
Why?
|
Gout Suppressants | 1 | 1996 | 176 | 0.030 |
Why?
|
Stress, Physiological | 2 | 1997 | 1407 | 0.030 |
Why?
|
Fee-for-Service Plans | 1 | 2019 | 713 | 0.030 |
Why?
|
Dilatation, Pathologic | 1 | 1995 | 527 | 0.030 |
Why?
|
Anemia, Sickle Cell | 1 | 1982 | 1065 | 0.030 |
Why?
|
Transplantation, Autologous | 3 | 2004 | 2118 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 1987 | 3928 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2018 | 1142 | 0.030 |
Why?
|
Thumb | 1 | 1995 | 232 | 0.030 |
Why?
|
Edema | 2 | 2010 | 764 | 0.030 |
Why?
|
Oscillometry | 1 | 1993 | 151 | 0.030 |
Why?
|
Cerebral Hemorrhage | 1 | 2004 | 2655 | 0.030 |
Why?
|
Drugs, Generic | 1 | 1998 | 457 | 0.030 |
Why?
|
Cardiac Output, Low | 1 | 1993 | 192 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2870 | 0.030 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2015 | 511 | 0.030 |
Why?
|
Comorbidity | 1 | 2007 | 10582 | 0.030 |
Why?
|
Family Health | 1 | 1997 | 1254 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 1 | 2013 | 610 | 0.030 |
Why?
|
Pyridines | 2 | 2010 | 2890 | 0.020 |
Why?
|
Internationality | 1 | 2017 | 1006 | 0.020 |
Why?
|
Lysosomal Storage Diseases | 1 | 2012 | 80 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1278 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2002 | 6844 | 0.020 |
Why?
|
Rest | 1 | 1996 | 941 | 0.020 |
Why?
|
Autopsy | 1 | 2015 | 1011 | 0.020 |
Why?
|
Organ Transplantation | 1 | 2001 | 1173 | 0.020 |
Why?
|
Kidney | 3 | 2012 | 7063 | 0.020 |
Why?
|
Leukapheresis | 2 | 2004 | 150 | 0.020 |
Why?
|
Creatinine | 1 | 1997 | 1916 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2019 | 2028 | 0.020 |
Why?
|
Aortic Valve | 2 | 1997 | 1968 | 0.020 |
Why?
|
Fatigue | 1 | 1998 | 1556 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2014 | 1885 | 0.020 |
Why?
|
Immunoblotting | 1 | 2013 | 1647 | 0.020 |
Why?
|
Recovery of Function | 1 | 2020 | 2978 | 0.020 |
Why?
|
Pancytopenia | 1 | 2010 | 102 | 0.020 |
Why?
|
Drug Costs | 1 | 1998 | 1196 | 0.020 |
Why?
|
Hematopoietic Stem Cell Mobilization | 2 | 2001 | 225 | 0.020 |
Why?
|
Endpoint Determination | 1 | 2012 | 592 | 0.020 |
Why?
|
Electric Impedance | 1 | 1993 | 792 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2666 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2002 | 505 | 0.020 |
Why?
|
Proteinuria | 2 | 2003 | 613 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1604 | 0.020 |
Why?
|
Bone Marrow | 1 | 2019 | 2926 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 1998 | 2079 | 0.020 |
Why?
|
Death | 1 | 2013 | 685 | 0.020 |
Why?
|
Young Adult | 2 | 2018 | 59980 | 0.020 |
Why?
|
Glucocorticoids | 1 | 1998 | 2163 | 0.020 |
Why?
|
Nifedipine | 2 | 1985 | 220 | 0.020 |
Why?
|
Muscle, Smooth | 2 | 2003 | 930 | 0.020 |
Why?
|
Bone and Bones | 1 | 2018 | 2587 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 1998 | 5537 | 0.020 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 1999 | 766 | 0.020 |
Why?
|
Morbidity | 1 | 2012 | 1754 | 0.020 |
Why?
|
Massachusetts | 2 | 2009 | 8890 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2018 | 1882 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 1996 | 1804 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4572 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3431 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1492 | 0.020 |
Why?
|
Nephelometry and Turbidimetry | 1 | 2005 | 91 | 0.020 |
Why?
|
Equipment Design | 1 | 1993 | 3489 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2009 | 4780 | 0.020 |
Why?
|
Intraoperative Period | 1 | 1986 | 512 | 0.020 |
Why?
|
Survivors | 1 | 1995 | 2381 | 0.010 |
Why?
|
Nervous System | 2 | 1998 | 543 | 0.010 |
Why?
|
Software | 1 | 2019 | 4472 | 0.010 |
Why?
|
Peripheral Nervous System Diseases | 2 | 1996 | 716 | 0.010 |
Why?
|
False Positive Reactions | 1 | 1987 | 959 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2014 | 18330 | 0.010 |
Why?
|
France | 1 | 2005 | 496 | 0.010 |
Why?
|
Cardiomegaly | 1 | 1987 | 591 | 0.010 |
Why?
|
Graft Rejection | 1 | 1997 | 4498 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2010 | 3587 | 0.010 |
Why?
|
Imidazoles | 1 | 2010 | 1169 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1992 | 6215 | 0.010 |
Why?
|
Motion | 1 | 1987 | 784 | 0.010 |
Why?
|
Protein Binding | 1 | 2015 | 9327 | 0.010 |
Why?
|
Transplantation Conditioning | 2 | 2001 | 1601 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2006 | 1154 | 0.010 |
Why?
|
Pulmonary Heart Disease | 1 | 1982 | 34 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2015 | 26325 | 0.010 |
Why?
|
Gene Frequency | 1 | 2009 | 3621 | 0.010 |
Why?
|
Factor X Deficiency | 1 | 2001 | 8 | 0.010 |
Why?
|
Immunoassay | 1 | 2005 | 744 | 0.010 |
Why?
|
Heart Block | 1 | 1983 | 391 | 0.010 |
Why?
|
Hemosiderin | 1 | 2001 | 41 | 0.010 |
Why?
|
Extracellular Space | 1 | 2003 | 563 | 0.010 |
Why?
|
Respiratory Function Tests | 1 | 2006 | 1695 | 0.010 |
Why?
|
Esophagus | 1 | 1987 | 1041 | 0.010 |
Why?
|
Lung | 1 | 2019 | 10076 | 0.010 |
Why?
|
Emergencies | 2 | 1985 | 1223 | 0.010 |
Why?
|
Mortality | 1 | 2012 | 2909 | 0.010 |
Why?
|
Hemosiderosis | 1 | 2001 | 66 | 0.010 |
Why?
|
Algorithms | 1 | 2001 | 14098 | 0.010 |
Why?
|
Maximum Tolerated Dose | 1 | 2003 | 896 | 0.010 |
Why?
|
Risk | 1 | 1992 | 9606 | 0.010 |
Why?
|
Mitochondria | 1 | 2013 | 3678 | 0.010 |
Why?
|
Body Temperature | 1 | 2003 | 780 | 0.010 |
Why?
|
Immunoelectrophoresis | 1 | 1999 | 94 | 0.010 |
Why?
|
Feasibility Studies | 2 | 2004 | 5311 | 0.010 |
Why?
|
Case Management | 1 | 2001 | 277 | 0.010 |
Why?
|
Statistics as Topic | 1 | 1986 | 2350 | 0.010 |
Why?
|
Aging | 1 | 1998 | 8729 | 0.010 |
Why?
|
Portugal | 1 | 1999 | 91 | 0.010 |
Why?
|
Asparagine | 1 | 1999 | 120 | 0.010 |
Why?
|
Multiple Organ Failure | 1 | 2001 | 389 | 0.010 |
Why?
|
Pedigree | 2 | 1999 | 4539 | 0.010 |
Why?
|
Phosphorylation | 1 | 2010 | 8310 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2001 | 13650 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1979 | 411 | 0.010 |
Why?
|
Paraproteins | 1 | 1998 | 38 | 0.010 |
Why?
|
Pain | 1 | 1993 | 5101 | 0.010 |
Why?
|
Diphosphonates | 1 | 1983 | 633 | 0.010 |
Why?
|
Microcirculation | 1 | 2003 | 1282 | 0.010 |
Why?
|
Life Tables | 1 | 1998 | 367 | 0.010 |
Why?
|
Upper Extremity | 1 | 2003 | 684 | 0.010 |
Why?
|
DNA Primers | 1 | 2002 | 2827 | 0.010 |
Why?
|
Tachycardia, Paroxysmal | 1 | 1977 | 30 | 0.010 |
Why?
|
Hepatomegaly | 1 | 1996 | 84 | 0.010 |
Why?
|
Karnofsky Performance Status | 1 | 1996 | 162 | 0.010 |
Why?
|
Lidocaine | 1 | 1979 | 545 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2001 | 13491 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2001 | 1733 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2003 | 1271 | 0.010 |
Why?
|
Adolescent | 3 | 2001 | 89046 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 1984 | 1794 | 0.010 |
Why?
|
Cysts | 1 | 2001 | 685 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1999 | 1531 | 0.010 |
Why?
|
Serine | 1 | 1999 | 828 | 0.010 |
Why?
|
Platelet Transfusion | 1 | 1998 | 301 | 0.010 |
Why?
|
Isoenzymes | 1 | 1979 | 1688 | 0.010 |
Why?
|
Liver Diseases | 1 | 1983 | 1304 | 0.010 |
Why?
|
Markov Chains | 1 | 1998 | 976 | 0.010 |
Why?
|
Models, Economic | 1 | 1998 | 719 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 2001 | 1144 | 0.010 |
Why?
|
Health Surveys | 1 | 2004 | 4056 | 0.010 |
Why?
|
Endocarditis, Bacterial | 1 | 1978 | 436 | 0.010 |
Why?
|
Kinetics | 1 | 2001 | 6287 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2002 | 4114 | 0.010 |
Why?
|
Streptococcal Infections | 1 | 1978 | 618 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5693 | 0.010 |
Why?
|
Child | 2 | 1997 | 80771 | 0.010 |
Why?
|
Erythrocyte Transfusion | 1 | 1998 | 575 | 0.010 |
Why?
|
Ventricular Function, Right | 1 | 1997 | 629 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2004 | 2099 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 6067 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 1998 | 1666 | 0.010 |
Why?
|
Drug Combinations | 1 | 1999 | 2086 | 0.010 |
Why?
|
Forecasting | 1 | 2001 | 2936 | 0.010 |
Why?
|
Renal Dialysis | 1 | 2001 | 1790 | 0.010 |
Why?
|
Cholesterol | 1 | 2001 | 2905 | 0.010 |
Why?
|
Mice | 2 | 2013 | 81912 | 0.010 |
Why?
|
Radiography | 1 | 1982 | 6975 | 0.010 |
Why?
|
Neutropenia | 1 | 1996 | 892 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2003 | 4424 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2001 | 2783 | 0.010 |
Why?
|
Drug Interactions | 1 | 1995 | 1419 | 0.010 |
Why?
|
Cardiovascular System | 1 | 1998 | 839 | 0.010 |
Why?
|
Patient Care Team | 1 | 2001 | 2516 | 0.010 |
Why?
|
Skin | 1 | 2003 | 4499 | 0.010 |
Why?
|
Hypotension | 1 | 1995 | 888 | 0.000 |
Why?
|
Electric Stimulation | 2 | 1985 | 1736 | 0.000 |
Why?
|
Boston | 1 | 2001 | 9360 | 0.000 |
Why?
|
Decision Support Techniques | 1 | 1998 | 2006 | 0.000 |
Why?
|
Gastrointestinal Diseases | 1 | 1996 | 1205 | 0.000 |
Why?
|
Colonic Neoplasms | 1 | 1978 | 2535 | 0.000 |
Why?
|
Macrophages | 1 | 2001 | 5785 | 0.000 |
Why?
|
Body Mass Index | 1 | 2003 | 13048 | 0.000 |
Why?
|
Endocardium | 1 | 1985 | 249 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 11872 | 0.000 |
Why?
|
Liver | 1 | 1998 | 7578 | 0.000 |
Why?
|
Coronary Disease | 1 | 1995 | 5914 | 0.000 |
Why?
|
Electrodes, Implanted | 1 | 1985 | 835 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 1978 | 6360 | 0.000 |
Why?
|
Spleen | 1 | 1985 | 2292 | 0.000 |
Why?
|
Necrosis | 1 | 1982 | 1614 | 0.000 |
Why?
|
Streptococcus | 1 | 1978 | 197 | 0.000 |
Why?
|